Seres Therapeutics (MCRB) Q1 2023 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.7
-0.62
-0.54
-0.46

Details

Expected EPS
-0.55
Actual EPS
-0.57
Surprise EPS
-0.02
Surprise Percent
+3.64%

Description

Seres Therapeutics (MCRB) has reported earnings of -0.57 per share for Q1 2023.

0 Comments

Share your thoughts